Order Article Reprints

Helderman RFCPA, Löke DR, Tanis PJ, Tuynman JB, Ceelen W, de Hingh IH, van der Speeten K, Franken NAP, Oei AL, Kok HP, et al. Preclinical In Vivo-Models to Investigate HIPEC; Current Methodologies and Challenges. Cancers. 2021; 13(14):3430. https://doi.org/10.3390/cancers13143430

Helderman, Roxan F. C. P. A., Daan R. Löke, Pieter J. Tanis, Jurriaan B. Tuynman, Wim Ceelen, Ignace H. de Hingh, Kurt van der Speeten, Nicolaas A. P. Franken, Arlene L. Oei, H. Petra Kok, and et al. 2021. "Preclinical In Vivo-Models to Investigate HIPEC; Current Methodologies and Challenges" Cancers 13, no. 14: 3430. https://doi.org/10.3390/cancers13143430

Helderman, R. F. C. P. A., Löke, D. R., Tanis, P. J., Tuynman, J. B., Ceelen, W., de Hingh, I. H., van der Speeten, K., Franken, N. A. P., Oei, A. L., Kok, H. P., & Crezee, J. (2021). Preclinical In Vivo-Models to Investigate HIPEC; Current Methodologies and Challenges. Cancers, 13(14), 3430. https://doi.org/10.3390/cancers13143430